Skip to content
Open access

REFCON: Reference-free and robust copy number inference in single-cell tumor transcriptomes

Aug 2026 · bioRxiv · 0 citations
Biology

TL;DR

REFCON is introduced, a deep-learning model that enables reference-free copy number profiling from scRNA-seq data collected without matched normals, and profiles pure tumors, generalizes to unseen tissues and platforms, and stays robust to cohort composition.

Abstract

Single-cell RNA sequencing (scRNA-seq) is widely used to infer copy number profiles from tumor cells. Existing methods build on a reference-based normalization paradigm: normalizing each tumor cell against a reference of normal cells, whether supplied, in-sample, or synthesized. This makes them reference-dependent and as a result, sensitive to cohort composition, and prone to false positives. To address these limitations, we introduce REFCON, a deep-learning model that enables reference-free copy number profiling from scRNA-seq data. REFCON estimates local copy-number deviations and jointly optimizes them into a genome-wide per-cell profile. It profiles pure tumors, generalizes to unseen tissues and platforms, and stays robust to cohort composition. Predicted copy number profiles distinguish malignant cells with high specificity, producing far fewer false-positive calls, and improve clonal reconstruction. The model can also benefit from reference cells when available, turning a field requirement into an optional refinement. Hence, REFCON extends reliable per-cell copy number profiling to the scRNA-seq data collected without matched normals.

Read PDF

Similar papers

Open access Aug 2026

Ultrafast and reference-free sequence discovery in single-cell data.

Malva is presented, a computational platform that enables ultrafast, species-agnostic and reference-free interrogation of the raw sequence space, enabling searching for any sequence, mutation, splice junction or pathogen, or spatial location of arbitrary transcripts.

D. León-Periñán, Nikos Karaiskos, N. Rajewsky · 1 citation
Open access Aug 2026

A statistical framework for disease classification with scRNA-Seq Data

This work introduces a two-stage statistical framework for interpretable patient-level disease classification from single-cell data, and recovered biologically coherent, cell-type specific gene signatures consistent with known disease mechanisms, demonstrating improved interpretability without sacrificing predictive ac...

Zhi-Wei Xiao, William Torous, Jeffrey B. Cheng et al. · 0 citations
Open access Sep 2026

Patient classification using single-cell RNA-sequencing data with deep learning convolutional neural networks

Single-cell RNA sequencing (scRNA-seq) enables gene expression profiling at the resolution of individual cells, revealing cellular heterogeneity that is obscured in bulk RNA-seq. While this offers a powerful lens to study disease-specific changes, leveraging scRNA-seq data for patient phenotype classification remai...

A. Oulas, N. Karathanasis, T. Lampadarios et al. · 0 citations
Open access Aug 2026

HopRatio: Profiling single-sample transcriptomic dysregulation using stable gene-ordering relationships

Summary Single-sample transcriptomic analysis can provide gene-level views of how individual tumors deviate from matched reference states, complementing cohort-level differential expression. Here, we present HopRatio, a rank-based framework that quantifies, for each gene in each sample, the fraction of stable reference...

Yue Zhao, Bo Gao, Rui-Zhong Chen · 0 citations
Open access Sep 2026

A single-cell RNA-seq catalog of ground truth gene coregulation

Single-cell RNA-sequencing measurements are uniquely well-poised to identify coregulated gene transcription. Coregulation should be apparent as correlation of expression levels, but at which unit to quantify expression for calculation of correlations is not clear. To enable evaluation of normalization methods for ident...

Valentine Svensson · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.